Finerenone, Liver Biomarkers, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: An Analysis of FINEARTS-HF
Gerard C.M Linssen, Morten Schou, Katja Rohwedder, Maria Borentain et al.
Journal
Circulation Heart Failure
Topics
Heart Failure Treatment and Management
article
Finerenone, Liver Biomarkers, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: An Analysis of FINEARTS-HF
Gerard C.M Linssen, Morten Schou, Katja Rohwedder, Maria Borentain, Rania Dayoub, Yoriko De Sanctis, A R Henderson, SJ Shah, Voors Aa, John J.V. McMurray, Jawad H. Butt, Bertram Pitt, Faiez Zannad, Cândida Fonseca, Subodh Verma, Mark C. Petrie, Carolyn S.P. Lam, Pardeep S. Jhund, Scott D. Solomon, Brian L. Claggett, Akshay S. Desai, Muthiah Vaduganathan, Johann Bauersachs, Michele Senni
article en
Abstract
No abstract available for this paper.
Publication Tag
Circulation Heart FailureVol. 19(2)
Institutions
Northwestern University (US), Brigham and Women's Hospital (US), St. Michael's Hospital (CA), Bayer (United States) (US), Inserm (FR), University of Groningen (NL), University of Toronto (CA), University of Michigan (US), Gentofte Hospital (DK), University Hospital Regensburg (DE), British Heart Foundation (GB), Medizinische Hochschule Hannover (DE), Centre Hospitalier Régional et Universitaire de Nancy (FR), Ospedale Papa Giovanni XXIII (IT), National University Heart Centre Singapore (SG), Ziekenhuis Groep Twente (NL), University of Milano-Bicocca (IT), Bayer (Germany) (DE), Universidade Nova de Lisboa (PT), Université de Lorraine (FR)